Redefining Cancer Care: Dr. Steven J. Frank on the Landmark Head & Neck Trial

Join us Friday, December 5, at 10:00 AM (EST) for a special NAPT webinar featuring an exclusive conversation with Dr. Steven J. Frank, Executive Director of the Particle Therapy Institute at MD Anderson.

Dr. Frank will unveil the results of his soon-to-be-published randomized clinical trial comparing outcomes for oropharyngeal cancer patients treated with proton therapy—a study poised to transform oncology practice worldwide.

This landmark research marks a pivotal shift in how head and neck cancers are treated, setting new benchmarks for standards of care and offering fresh hope for patients. Attendees will gain firsthand insight into the global impact of these findings and their implications for the future of precision cancer treatment.

Presented as part of NAPT’s Quarterly Research Highlights Series, showcasing the most significant advancements in proton therapy.

Panelist:
Steven J. Frank, MD Executive Director, Particle Therapy Institute, MD Anderson Cancer Center
J.W. Snider, MD, Proton International (Moderator)

Pre-registration is required. Open to general public, both members and non-members.